Vanderbilt-Ingram Cancer Center Archive — Page 17 of 28

Studies by Andrew Glazer, PhD, Giovanni Davogustto, MD, and colleagues found that genetic testing with information from electronic health records can reveal undiagnosed heart rhythm disorders.
April 28, 2022

Studies combine genetic testing, electronic health records to find undiagnosed diseases

Combining genetic testing with information from electronic health records revealed undiagnosed heart rhythm disorders and new conditions associated with inherited cancer gene mutations.

April 25, 2022

Molecular testing across tumor types

The KRAS inhibitor sotorasib is newly approved for one kind of lung cancer; Vanderbilt researchers ask if it should be considered for another type if the tumor has the gene mutation it targets.

April 22, 2022

“Our family is forever grateful”: Latest DAISY Awards honor seven extraordinary nurses

DAISY Awards are given to great nurses all over the United States and in many other countries

A VUMC study found that following up with patients within the week after their hospital discharge as a stand-alone intervention has no impact on readmissions, mortality or patient satisfaction.
April 12, 2022

Financial impact of prior authorization

Prior authorization — health insurer approval of a medical intervention prior to treatment — costs more than $40 million for U.S. academic radiation oncology practices, with questionable value added to patient care.

March 31, 2022

Clip In 4 the Cure

More than 300 riders participated in the inaugural Clip In 4 the Cure, a relay-style, team cycling event that supported cancer initiatives at Vanderbilt-Ingram Cancer Center and Monroe Carell Jr. Children’s Hospital at Vanderbilt.

March 24, 2022

Stress in young adult cancer patients and caregivers

Adolescent and young adult oncology patients and caregivers experience psychosocial impairment and financial toxicity at the time of cancer diagnosis, findings that will inform interventions to support patient and caregiver well-being.